ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-4966ometendo-4966Research ArticleСтатьиArticlesВлияние антипсихотических препаратов на обмен веществMetabolic effects of antipsychotic drugsUnilinenO Aolga84@yandex.ruStarostinaE Gelena.starostina@rambler.ru20121509201293№3 (2012)1113Copyright © Unilinen O.A., Starostina E.G., 20122012Unilinen O.A., Starostina E.G.Unilinen O.A., Starostina E.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/4966ReferencesGury C. Schizophrenia, diabetes mellitus and antipsychotics. Encephale. 2004 Jul-Aug;30(4):382–91.Gury C. Schizophrenia, diabetes mellitus and antipsychotics. Encephale. 2004 Jul-Aug;30(4):382–91.Weiden P, Mackell J, McDonnell D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Res. 2004;66:51–57.Weiden P, Mackell J, McDonnell D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Res. 2004;66:51–57.Fiedorowicz J, Miller D, Jeffrey R, Chadi A, Ellingrod L, William G. Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Curr Psychiatry Rev. 2012;8(1):25–36.Fiedorowicz J, Miller D, Jeffrey R, Chadi A, Ellingrod L, William G. Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Curr Psychiatry Rev. 2012;8(1):25–36.Newcomer J. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19 (Suppl 1):1–93.Newcomer J. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19 (Suppl 1):1–93.Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejias M, Hernаndez L. Antipsychotic Drugs and Obesity: Is Prolactin Involved? Can J Psychiatry. 2001;46:829–834.Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejias M, Hernаndez L. Antipsychotic Drugs and Obesity: Is Prolactin Involved? Can J Psychiatry. 2001;46:829–834.Melkersson K, Berinder K, Hulting A. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses. Neuro Endocrinol Lett. 2011;32(4):428–36.Melkersson K, Berinder K, Hulting A. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses. Neuro Endocrinol Lett. 2011;32(4):428–36.Lieberman J. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine. 2005;353:1209–23.Lieberman J. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine. 2005;353:1209–23.Haupt D, Newcomer J. Hyperglycemia and antipsychotic medications. J Clin Psychiatry. 2001;62 Suppl 27:15–26; discussion 40–1.Haupt D, Newcomer J. Hyperglycemia and antipsychotic medications. J Clin Psychiatry. 2001;62 Suppl 27:15–26; discussion 40–1.
The authors declare that there are no conflicts of interest present.